Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines
NCT01189747
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
446
Enrollment
INDUSTRY
Sponsor class
Conditions
Lateral Canthus Rhytides
Crow's Feet Lines
Interventions
BIOLOGICAL:
onabotulinumtoxinA
DRUG:
normal saline
Sponsor
Allergan